UBS AM Portfolio holdings
UBS Asset Management (UBS AM), a division of UBS Group AG with origins tied to the bank’s founding in 1862, is headquartered in Zurich, Switzerland, and manages hundreds of billions in assets for institutional, intermediary, and wealth management clients globally. Specializing in a broad range of investment strategies—including equities, fixed income, multi-asset, alternatives, and sustainable investing—UBS AM leverages the firm’s extensive research capabilities and global network to deliver tailored solutions. Known for its focus on risk management and innovation, it offers products like ETFs, index funds, and private market investments, catering to diverse needs from pension funds to high-net-worth individuals. As part of UBS’s broader ecosystem, UBS AM combines Swiss precision with a commitment to ESG principles, solidifying its position as a leader in the asset management industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Infosys
INFY
|
+$767M |
| 2 |
Amazon
AMZN
|
+$288M |
| 3 |
Alphabet (Google) Class A
GOOGL
|
+$287M |
| 4 |
NVIDIA
NVDA
|
+$259M |
| 5 |
Alphabet (Google) Class C
GOOG
|
+$249M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alibaba
BABA
|
+$347M |
| 2 |
TWTR
Twitter, Inc.
TWTR
|
+$316M |
| 3 |
Citigroup
C
|
+$269M |
| 4 |
Charter Communications
CHTR
|
+$229M |
| 5 |
NetEase
NTES
|
+$211M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 25.35% |
| 2 | Consumer Discretionary | 13.14% |
| 3 | Financials | 12.19% |
| 4 | Healthcare | 12.04% |
| 5 | Communication Services | 9.9% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
CYBR
901
DELISTED
CyberArk
CYBR
| $15.1M | 0.01% |
116,608
+4,627
| +4% | +$701K |
|
|
MSP
902
DELISTED
Datto Holding Corp.
MSP
| $15M | 0.01% |
+654,610
| New | +$16.4M |
|
903
PTC Therapeutics
PTCT
$6.12B
| $15M | 0.01% |
316,202
-127,940
| -29% | -$7.6M |
|
904
Avnet
AVT
$7.92B
| $14.9M | 0.01% |
359,535
-30,645
| -8% | -$1.18M |
|
905
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
$17.9B
| – | – |
0
| – | – |
|
906
Jabil
JBL
$35.8B
| $14.9M | 0.01% |
284,948
-16,045
| -5% | -$731K |
|
|
SAGE
907
DELISTED
Sage Therapeutics
SAGE
| $14.8M | 0.01% |
197,634
-211,166
| -52% | -$17.3M |
|
908
Relay Therapeutics
RLAY
$4.33B
| $14.7M | 0.01% |
425,451
-58,944
| -12% | -$2.56M |
|
909
Bruker
BRKR
$8.14B
| $14.7M | 0.01% |
228,259
+5,627
| +3% | +$338K |
|
910
argenx
ARGX
$54.1B
| $14.7M | 0.01% |
53,265
-16,831
| -24% | -$5.32M |
|
|
KW
911
DELISTED
Kennedy-Wilson Holdings
KW
| $14.6M | 0.01% |
720,567
+49,769
| +7% | +$934K |
|
912
WEX
WEX
$6.31B
| $14.5M | 0.01% |
69,305
-318
| -0.5% | -$67.1K |
|
913
Casey's General Stores
CASY
$30.9B
| $14.3M | 0.01% |
66,187
-1,030
| -2% | -$206K |
|
914
Sunstone Hotel Investors
SHO
$2.06B
| $14.3M | 0.01% |
1,145,528
-9,988
| -0.9% | -$119K |
|
915
Four Corners Property Trust
FCPT
$2.75B
| $14.2M | 0.01% |
519,655
+66,418
| +15% | +$1.83M |
|
916
Encompass Health
EHC
$12.4B
| $14.2M | 0.01% |
218,121
+17,844
| +9% | +$1.16M |
|
|
BZUN
917
Baozun
BZUN
$172M
| $14.1M | 0.01% |
369,793
+9,916
| +3% | +$423K |
|
918
National Health Investors
NHI
$3.65B
| $14.1M | 0.01% |
194,708
-64,262
| -25% | -$4.48M |
|
|
AMED
919
DELISTED
Amedisys
AMED
| $14M | 0.01% |
52,717
-659
| -1% | -$186K |
|
920
Penumbra
PEN
$12.8B
| $13.9M | 0.01% |
51,516
-6,142
| -11% | -$1.59M |
|
921
Five Below
FIVE
$13.5B
| $13.9M | 0.01% |
72,827
-9,760
| -12% | -$1.84M |
|
922
Darling Ingredients
DAR
$9.44B
| $13.9M | 0.01% |
188,836
-451
| -0.2% | -$31K |
|
923
Polaris
PII
$4.07B
| $13.9M | 0.01% |
104,054
-8,568
| -8% | -$1.04M |
|
924
XP
XP
$8.39B
| $13.9M | 0.01% |
368,720
+5,376
| +1% | +$230K |
|
925
ITT
ITT
$19.1B
| $13.9M | 0.01% |
152,536
-4,344
| -3% | -$358K |
|
Similar funds
UBS AM's Q1 2021 Portfolio in Review
As of Q1 2021, UBS AM held 2,645 positions worth $226B, up 6% from $213B the previous quarter. Its ten largest holdings account for 22% of the portfolio.
Trading was light in Q1 2021: portfolio turnover was 4.9%. UBS AM opened 86 new positions and exited 44, leaving the 2,645-position portfolio largely intact.
By sector, the portfolio is most concentrated in Technology at 25% of assets, up from 25% a quarter earlier, followed by Consumer Discretionary and Financials.
- UBS AM's largest Q1 2021 buy was Seagen Inc. Common Stock: 966,114 shares worth $134M.
- UBS AM added most to Infosys in Q1 2021, an estimated $767M increase.
- UBS AM's biggest Q1 2021 reduction was Alibaba, cutting an estimated $347M.
- UBS AM fully exited Lumen in Q1 2021, selling an estimated $45.5M.
- UBS AM's ten largest holdings make up 22% of its $226B portfolio in Q1 2021.
- UBS AM opened 86 new positions and closed 44 in Q1 2021.
- UBS AM's portfolio value rose 6% quarter-over-quarter to $226B.
Based on UBS AM's 13F filing for Q1 2021, filed 14 May 2021.